BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 13163577)

  • 1. [Studies on the pathogenesis of kuru; a clinical, pathological and epidemiological study of a chronic, progressive, degenerative disease of the central nervous system achieving epidemic proportions among the natives of the Eastern Highlands of New Guinea].
    GAJDUSEK DC; ZIGAS V
    Klin Wochenschr; 1958 May; 36(10):445-59. PubMed ID: 13550856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on copper metabolism in several forms of schizophrenia].
    OZEK M
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1957; 195(4):408-23. PubMed ID: 13435853
    [No Abstract]   [Full Text] [Related]  

  • 3. [On a hereditary essential tremor with brain atrophy].
    Kehrer HE
    Arch Psychiatr Nervenkr (1970); 1965 Aug; 207(1):6-22. PubMed ID: 5294497
    [No Abstract]   [Full Text] [Related]  

  • 4. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration.
    UZMAN LL
    AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
    [No Abstract]   [Full Text] [Related]  

  • 6. Histochemical demonstration of copper in a case of hepatolenticular degeneration.
    GREEN CL
    Am J Pathol; 1955; 31(3):545-53. PubMed ID: 14376512
    [No Abstract]   [Full Text] [Related]  

  • 7. [The content of copper in the tissues of patients with hepatolenticular degeneration].
    BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1141-5. PubMed ID: 13687972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Copper in hepatolenticular degeneration (H.L.D.)].
    Pardo R; Rubio HH
    Acta Gastroenterol Latinoam; 1971; 3(1):27-8. PubMed ID: 5135751
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic copper metabolism: insights from genetic disease.
    Tao TY; Gitlin JD
    Hepatology; 2003 Jun; 37(6):1241-7. PubMed ID: 12773998
    [No Abstract]   [Full Text] [Related]  

  • 11. Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism.
    Huster D; Lutsenko S
    Mol Biosyst; 2007 Dec; 3(12):816-24. PubMed ID: 18000558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson's disease: clinical management and therapy.
    Brewer GJ; Askari FK
    J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.